Study to test new tinnitus 'treatment'

A new clinical trial is to test whether a pocket-sized device that uses sound simulation to reboot faulty 'wiring' in the brain could cure people with the debilitating hearing disorder tinnitus.

The CR neuromodulation device delivers specific sequences of sounds to disrupt the pattern of neurons firing in the brain. It is believed that conditions such as hearing loss can cause neurons in the brain to fire simultaneously instead of in a which can cause an overload and lead to a ringing or buzzing in the ear, the classic symptom of tinnitus.

The study is being led by the National Biomedical Research Unit in Hearing (NBRUH) which is funded by the National Institute for Health Research (NIHR), a partnership bringing together expertise from researchers at The University of Nottingham and the Medical Research Council Institute of Hearing with leading clinicians from Nottingham University Hospitals NHS Trust.

Dr Derek Hoare, a research fellow at the NBRUH, said: "In the UK, around five million people suffer from tinnitus, a debilitating condition which can be exceptionally difficult to treat due to the huge variation in symptoms and severity between individual patients.

"We know there are very many people out there suffering with tinnitus who have tried a number of different treatments including , sound therapies, counselling and other alternative medicines such as acupuncture but to no avail.

"We want to scientifically establish whether this new method of sound simulation could offer patients a new hope for treating tinnitus, which can have such a distressing impact on people's day to day lives."

Tinnitus is a secondary symptom usually resulting from damage to the ears, including hearing loss following exposure to loud noises, congenital hearing loss, ear infections and ear death caused by exposure to a number of different drugs.

The revolutionary CR® neuromodulation device is already being marketed by the private healthcare sector both in the UK and in Germany, where it was originally manufactured and where an exploratory study has already produced promising results.

Funded with just over £345,000 from the the specialist private audiologists The Tinnitus Clinic in London, the study will also involve collaboration with experts at the Ear Institute at University College London (UCL).

The scientists will be looking to recruit patients who have suffered from bothersome tinnitus for at least three months but are not currently receiving any treatment for the condition. Those with associated will need to forego the use of their normal hearing aid for the four to six hours per day when the device needs to be worn.

The study will involve two groups of participants, one of which will be fitted with the CR® neuromodulation device and the other of which will be fitted with a placebo device. Over a period of three months, the researchers will then monitor the effect of wearing the device on the patient's condition through a series of hearing tests, questionnaires and EEG recordings of the electrical activity of their brain.

After three months, all patients — even those who previously received a placebo — will be fitted with a working device which they will be free to keep.

The researchers hope to be able to prove that by disrupting the abnormal firing of neurons in the brain the device can encourage them to return to a normal healthy pattern, eradicating the symptoms of . In some cases, patients may find the device has permanently improved their symptoms, with potentially no further treatment needed in the future.

Related Stories

Silence may lead to phantom noises misinterpreted as tinnitus

Jan 01, 2008

Phantom noises, that mimic ringing in the ears associated with tinnitus, can be experienced by people with normal hearing in quiet situations, according to new research published in the January 2008 edition of Otolaryngology ...

Teaching about hearing can save young people's ears

Mar 05, 2012

Many adolescents frequently expose their ears to loud sounds, for example from portable music players. Some of them may think that 'the doctor said that my hearing is good, so I guess I can handle the loud volume'. A new ...

Recommended for you

Ebola: Five questions about the killer virus

26 minutes ago

The highly contagious Ebola virus, which has killed more than 4,500 people in west Africa since December and has fueled global alarm, is among the most dangerous ever identified.

Ebola fear, monitoring eases for some in Dallas

36 minutes ago

The people closest to Ebola victim Thomas Eric Duncan are trying to resume their lives now that they have come out of a 21-day incubation period without developing symptoms of the disease.

Third UN employee dies from Ebola

46 minutes ago

A UN staff member in Sierra Leone has died from Ebola, the third employee from the world organization to succumb to the deadly virus, the UN spokesman said Monday.

Canadian Ebola vaccine sent to WHO for testing

56 minutes ago

The first batch of an experimental Ebola vaccine developed by Canadian scientists was sent to Switzerland on Monday for testing by the World Health Organization, officials said.

User comments